234 related articles for article (PubMed ID: 16082251)
1. Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer.
Nassar A; Amin MB; Sexton DG; Cohen C
Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):252-5. PubMed ID: 16082251
[TBL] [Abstract][Full Text] [Related]
2. Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions.
Zhou M; Chinnaiyan AM; Kleer CG; Lucas PC; Rubin MA
Am J Surg Pathol; 2002 Jul; 26(7):926-31. PubMed ID: 12131161
[TBL] [Abstract][Full Text] [Related]
3. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
Zhou M; Jiang Z; Epstein JI
Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
[TBL] [Abstract][Full Text] [Related]
4. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
[TBL] [Abstract][Full Text] [Related]
6. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
7. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
Adley BP; Yang XJ
Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
[TBL] [Abstract][Full Text] [Related]
8. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
[TBL] [Abstract][Full Text] [Related]
9. Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases.
Jiang Z; Fanger GR; Woda BA; Banner BF; Algate P; Dresser K; Xu J; Chu PG
Hum Pathol; 2003 Aug; 34(8):792-6. PubMed ID: 14506641
[TBL] [Abstract][Full Text] [Related]
10. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues.
Hameed O; Sublett J; Humphrey PA
Am J Surg Pathol; 2005 May; 29(5):579-87. PubMed ID: 15832080
[TBL] [Abstract][Full Text] [Related]
12. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.
Beach R; Gown AM; De Peralta-Venturina MN; Folpe AL; Yaziji H; Salles PG; Grignon DJ; Fanger GR; Amin MB
Am J Surg Pathol; 2002 Dec; 26(12):1588-96. PubMed ID: 12459625
[TBL] [Abstract][Full Text] [Related]
13. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.
Jiang Z; Li C; Fischer A; Dresser K; Woda BA
Am J Clin Pathol; 2005 Feb; 123(2):231-6. PubMed ID: 15842047
[TBL] [Abstract][Full Text] [Related]
14. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
Zhou M; Aydin H; Kanane H; Epstein JI
Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314
[TBL] [Abstract][Full Text] [Related]
15. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
Kunju LP; Chinnaiyan AM; Shah RB
Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
[TBL] [Abstract][Full Text] [Related]
16. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.
Wu CL; Yang XJ; Tretiakova M; Patton KT; Halpern EF; Woda BA; Young RH; Jiang Z
Hum Pathol; 2004 Aug; 35(8):1008-13. PubMed ID: 15297968
[TBL] [Abstract][Full Text] [Related]
17. Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
Rubin MA; Zerkowski MP; Camp RL; Kuefer R; Hofer MD; Chinnaiyan AM; Rimm DL
Am J Pathol; 2004 Mar; 164(3):831-40. PubMed ID: 14982837
[TBL] [Abstract][Full Text] [Related]
18. Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues.
Gologan A; Bastacky S; McHale T; Yu J; Cai C; Monzon-Bordonaba F; Dhir R
Am J Surg Pathol; 2005 Nov; 29(11):1435-41. PubMed ID: 16224209
[TBL] [Abstract][Full Text] [Related]
19. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma.
Skinnider BF; Oliva E; Young RH; Amin MB
Am J Surg Pathol; 2004 Jun; 28(6):701-5. PubMed ID: 15166661
[TBL] [Abstract][Full Text] [Related]
20. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.
Andrews C; Humphrey PA
Am J Surg Pathol; 2014 Jul; 38(7):1007-12. PubMed ID: 24705308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
